These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10567677)

  • 1. Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.
    Zagozdzon R; Golab J; Mucha K; Foroncewicz B; Jakobisiak M
    Int J Mol Med; 1999 Dec; 4(6):645-8. PubMed ID: 10567677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.
    Zagozdzon R; Stokłosa T; Gołab J; Giermasz A; Dabrowska A; Lasek W; Jakóbisiak M
    Anticancer Res; 1997; 17(6D):4493-8. PubMed ID: 9494557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
    Zagozdzon R; Gołab J; Stokłosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakóbisiak M
    Int J Cancer; 1998 Aug; 77(5):720-7. PubMed ID: 9688305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice.
    Gołab J; Stokłosa T; Zagozdzon R; Kaca A; Giermasz A; Pojda Z; Machaj E; Dabrowska A; Feleszko W; Lasek W; Iwan-Osiecka A; Jakóbisiak M
    Ann Oncol; 1998 Jan; 9(1):63-9. PubMed ID: 9541685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
    Lasek W; Wańkowicz A; Kuc K; Feleszko W; Gołab J; Giermasz A; Wiktor-Jedrzejczak W; Jakóbisiak M
    Cancer Immunol Immunother; 1995 May; 40(5):315-21. PubMed ID: 7600564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.
    Cao L; Zeng Q; Xu C; Shi S; Zhang Z; Sun X
    Mol Pharm; 2013 May; 10(5):1804-14. PubMed ID: 23534449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
    Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice.
    Kozar K; Kamiński R; Switaj T; Ołdak T; Machaj E; Wysocki PJ; Mackiewicz A; Lasek W; Jakóbisiak M; Gołab J
    Clin Cancer Res; 2003 Aug; 9(8):3124-33. PubMed ID: 12912964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL; Stampfl S; Zimmerman RJ
    Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
    Fujimoto S; Chikazawa H
    Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiated antitumor effects of interleukin 12 and interferon alpha against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Gołab J; Jakóbisiak M
    Neoplasma; 2001; 48(5):358-61. PubMed ID: 11845979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
    Meng X; Du G; Ye L; Sun S; Liu Q; Wang H; Wang W; Wu Z; Tian J
    Int J Immunopathol Pharmacol; 2017 Sep; 30(3):215-226. PubMed ID: 28604143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.
    Lasek W; Golab J; Maśliński W; Switaj T; Bałkowiec EZ; Stokłosa T; Giermasz A; Malejczyk M; Jakóbisiak M
    Eur Cytokine Netw; 1999 Sep; 10(3):345-56. PubMed ID: 10477391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts.
    Moschetta M; Pretto F; Berndt A; Galler K; Richter P; Bassi A; Oliva P; Micotti E; Valbusa G; Schwager K; Kaspar M; Trachsel E; Kosmehl H; Bani MR; Neri D; Giavazzi R
    Cancer Res; 2012 Apr; 72(7):1814-24. PubMed ID: 22392081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
    Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
    Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).
    Shin HJ; Kim YS; Kwak YS; Song YB; Kim YS; Park JD
    Planta Med; 2004 Nov; 70(11):1033-8. PubMed ID: 15549658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.
    Zhong H; Han B; Tourkova IL; Lokshin A; Rosenbloom A; Shurin MR; Shurin GV
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5455-62. PubMed ID: 17875775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
    Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.